A significant reduction in antibodies against oxidized LDL was seen in the aggressive (13.4%; P < 0.001)
atorvastatin 40mg for 8 weeks and thereafter atorvastatin 80 mg for the final 8 weeks (aggressive treatment)
baseline
antibodies against oxidized LDL